Chronic Bronchitis: Clinical Trials

18 trials for Chronic Bronchitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 6 unknown, 2 terminated, 2 withdrawn. 18 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 418Completed 8, Unknown 6, Terminated 2, Withdrawn 2

Follow Chronic Bronchitis: new trials by email Literature Review of Chronic Bronchitis trials Research Report on Chronic Bronchitis

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Explore if Long-term Use of Mucinex Can Help With Symptoms in Patients With Stable Chronic Bronchitis.
Guafenesin tablets - Chronic Bronchitis
Phase 4CompletedAmerican Health Research822023-07-172026-03-20
Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPD
Inactivated COVID-19 vaccine - COVID-19, Chronic Bronchitis
Phase 4UnknownChina National Biotec Group Company Limited4002021-12-012021-11-02
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD
Inactivated COVID-19 vaccine - COVID-19, Chronic Bronchitis
Phase 4UnknownChina National Biotec Group Company Limited4002021-10-082021-10-22
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD
Inactivated COVID-19 vaccine - COVID-19, Chronic Bronchitis
Phase 4UnknownChina National Biotec Group Company Limited4002021-10-082021-10-22
Effect of Zhuli Capsule on Phlegm-heat Syndrome (Tan-re Zheng)
Zhuli capsule, Placebo, Standard medical treatment - Chronic Obstructive Pulmonary Disease, Chronic Bronchitis
Phase 4UnknownZhong Wang3242021-07-012021-06-15
VX-770 for the Treatment of Chronic Bronchitis
Ivacaftor (VX-770) - Chronic Bronchitis
Phase 4WithdrawnUniversity of Alabama at Birmingham2020-01-012022-02-17
Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis
Losartan 50 mg, Losartan 100 mg - COPD, Chronic Bronchitis
Phase 4TerminatedUniversity of Miami312016-03-312020-08-20
The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis
Roflumilast, Placebo - COPD, Chronic Bronchitis
Phase 4CompletedJohns Hopkins University122013-03-182017-07-27
Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography
Nebulized arformoterol, Salmeterol - Chronic Obstructive Pulmonary Disease, COPD
Phase 4UnknownUniversity of California, Los Angeles202011-06-012012-07-20
Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype
Combined Training (endurance and strength exercises) - Obstructive Chronic Pulmonary Disease, Emphysema
Phase 4UnknownHospitales Universitarios Virgen del Rocío302011-01-012011-09-09
Efficacy of Losartan in Preventing Progression of COPD
Losartan, Placebo - COPD, Emphysema
Phase 4CompletedJohns Hopkins University1062008-07-012017-04-25
Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis
Avelox (Moxifloxacin, BAY12-8039), Amoxicillin clavulanic acid - Chronic Bronchitis
Phase 4CompletedBayer13722008-03-012014-12-01
Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)
formoterol fumarate - Chronic Obstructive Pulmonary Disease, COPD
Phase 4WithdrawnUniversity of California, Los Angeles2008-03-012016-08-04
Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients
Formoterol plus Placebo (Tiotropium), Formoterol plus Tiotropium - Pulmonary Disease, Chronic Obstructive, Chronic Bronchitis
Phase 4CompletedFederal University of São Paulo332007-11-012010-01-20
KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections
Telithromycin, Azithromycin - Respiratory Tract Infections, Chronic Bronchitis
Phase 4TerminatedSanofi20512004-10-012009-08-27
Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
pneumatic vest, placebo pneumatic vest - COPD, Chronic Bronchitis
Phase 4CompletedJohns Hopkins University502004-05-012018-10-19
PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis
telithromycin - Chronic Bronchitis
Phase 4CompletedSanofi56602004-01-012011-06-08
Inhaled Steroid Reduces Systemic Inflammation in COPD
inhaled fluticasone 500 mcg b.i.d. - Chronic Obstructive Pulmonary Disease, Emphysema
Phase 4CompletedUniversity of British Columbia502002-01-012010-07-28

Narrower conditions

Bronchitis, Chronic (18)  ·  Pulmonary Disease, Chronic Obstructive (14)  ·  Emphysema (7)  ·  COVID-19 (3)  ·  Smoking (3)  ·  Lung Diseases (2)  ·  Bronchitis (1)  ·  Dyspnea (1)  ·  Inflammation (1)  ·  Pneumonia (1)  ·  Pulmonary Emphysema (1)  ·  Respiratory Tract Infections (1)

Broader conditions

Bronchial Diseases (18)  ·  Chronic Disease (18)  ·  Disease Attributes (18)  ·  Infections (18)  ·  Lung Diseases, Obstructive (18)  ·  Pathologic Processes (18)  ·  Pathological Conditions, Signs and Symptoms (18)  ·  Respiratory Tract Diseases (18)  ·  Bronchitis (17)  ·  Respiratory Tract Infections (17)  ·  Lung Diseases (16)  ·  Pulmonary Disease, Chronic Obstructive (4)  ·  Behavior (3)  ·  Coronaviridae Infections (3)  ·  Coronavirus Infections (3)

Interventions

Formoterol Fumarate (3)  ·  Losartan (2)  ·  Sugars (2)  ·  telithromycin (2)  ·  Acetylcysteine (1)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Azithromycin (1)  ·  Moxifloxacin (1)  ·  Roflumilast (1)  ·  Salmeterol Xinafoate (1)  ·  Tiotropium Bromide (1)  ·  ivacaftor (1)

Sponsors

China National Biotec Group Company Limited (3)  ·  Johns Hopkins University (3)  ·  Sanofi (2)  ·  University of California, Los Angeles (2)  ·  American Health Research (1)  ·  Bayer (1)  ·  Federal University of São Paulo (1)  ·  Hospitales Universitarios Virgen del Rocío (1)  ·  University of Alabama at Birmingham (1)  ·  University of British Columbia (1)  ·  University of Miami (1)  ·  Zhong Wang (1)

Countries

United States (9)  ·  China (5)  ·  Canada (3)  ·  Spain (3)  ·  Belgium (2)  ·  Brazil (2)  ·  France (2)  ·  Andorra (1)  ·  Argentina (1)  ·  Australia (1)  ·  Chile (1)  ·  Colombia (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Germany (1)

Top investigators

Hanqing He (2)  ·  Beth Laube, PhD (1)  ·  Donald P Tashkin, M.D. (1)  ·  Eric Kleerup, M.D. (1)  ·  Gilles Perdriset, MD (1)  ·  Gregory B Diette, M.D.,M.H.S (1)  ·  J Alberto Neder, MD, phD (1)  ·  Nadia Hansel, MD MPH (1)  ·  Ortega F Ruiz, Doctor (1)  ·  Paul Man, MD (1)  ·  Phyllis Diener, BS, MT (ASCP) (1)  ·  Rafael Calderon, MD (1)  ·  Robert A. Wise, MD (1)  ·  Selwyn Spangenthal, MD (1)

Results publications

PMID 15229100, PMID 16113473, PMID 20580216, PMID 21760724, PMID 26082623

NIH funding

P50HL084945 (1), R01HL133240 (1), R01HL139365 (1)